Stem cell therapies in patients with single ventricle physiology

Suguru Tarui, Shunji Sano, Hidemasa Oh

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Single ventricle physiology, especially hypoplastic left heart syndrome, is one of the most high-risk lesions in children with congenital heart disease, and the ensuing heart failure remains as a major problem related to adverse outcomes in these patients. The field of stem cell therapy for heart failure has shown striking advances during the past 10 years, and many clinical trials using stem cell technologies have been conducted in adults, which suggest that stem cell therapy is associated with long-term improvement in cardiac function. Cardiac progenitor cells have recently been discovered, and their strong regenerative ability has been demonstrated in several studies. Although no large clinical trials have been performed in the field of congenital heart disease, recent investigations indicate that stem cell therapy may hold great potential to treat children with cardiac defects.

Original languageEnglish
Pages (from-to)77-81
Number of pages5
JournalMethodist DeBakey cardiovascular journal
Volume10
Issue number2
Publication statusPublished - Apr 1 2014

Fingerprint

Cell- and Tissue-Based Therapy
Stem Cells
Heart Diseases
Heart Failure
Clinical Trials
Hypoplastic Left Heart Syndrome
Technology

Keywords

  • cardiac progenitors
  • cell therapy
  • congenital heart disease
  • hypoplastic left heart syndrome
  • single ventricle physiology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Stem cell therapies in patients with single ventricle physiology. / Tarui, Suguru; Sano, Shunji; Oh, Hidemasa.

In: Methodist DeBakey cardiovascular journal, Vol. 10, No. 2, 01.04.2014, p. 77-81.

Research output: Contribution to journalArticle

@article{a32104d2a8a1496cb3bc358bdc7b73f4,
title = "Stem cell therapies in patients with single ventricle physiology",
abstract = "Single ventricle physiology, especially hypoplastic left heart syndrome, is one of the most high-risk lesions in children with congenital heart disease, and the ensuing heart failure remains as a major problem related to adverse outcomes in these patients. The field of stem cell therapy for heart failure has shown striking advances during the past 10 years, and many clinical trials using stem cell technologies have been conducted in adults, which suggest that stem cell therapy is associated with long-term improvement in cardiac function. Cardiac progenitor cells have recently been discovered, and their strong regenerative ability has been demonstrated in several studies. Although no large clinical trials have been performed in the field of congenital heart disease, recent investigations indicate that stem cell therapy may hold great potential to treat children with cardiac defects.",
keywords = "cardiac progenitors, cell therapy, congenital heart disease, hypoplastic left heart syndrome, single ventricle physiology",
author = "Suguru Tarui and Shunji Sano and Hidemasa Oh",
year = "2014",
month = "4",
day = "1",
language = "English",
volume = "10",
pages = "77--81",
journal = "Methodist DeBakey cardiovascular journal",
issn = "1947-6094",
publisher = "Methodist DeBakey Heart & Vascular Center",
number = "2",

}

TY - JOUR

T1 - Stem cell therapies in patients with single ventricle physiology

AU - Tarui, Suguru

AU - Sano, Shunji

AU - Oh, Hidemasa

PY - 2014/4/1

Y1 - 2014/4/1

N2 - Single ventricle physiology, especially hypoplastic left heart syndrome, is one of the most high-risk lesions in children with congenital heart disease, and the ensuing heart failure remains as a major problem related to adverse outcomes in these patients. The field of stem cell therapy for heart failure has shown striking advances during the past 10 years, and many clinical trials using stem cell technologies have been conducted in adults, which suggest that stem cell therapy is associated with long-term improvement in cardiac function. Cardiac progenitor cells have recently been discovered, and their strong regenerative ability has been demonstrated in several studies. Although no large clinical trials have been performed in the field of congenital heart disease, recent investigations indicate that stem cell therapy may hold great potential to treat children with cardiac defects.

AB - Single ventricle physiology, especially hypoplastic left heart syndrome, is one of the most high-risk lesions in children with congenital heart disease, and the ensuing heart failure remains as a major problem related to adverse outcomes in these patients. The field of stem cell therapy for heart failure has shown striking advances during the past 10 years, and many clinical trials using stem cell technologies have been conducted in adults, which suggest that stem cell therapy is associated with long-term improvement in cardiac function. Cardiac progenitor cells have recently been discovered, and their strong regenerative ability has been demonstrated in several studies. Although no large clinical trials have been performed in the field of congenital heart disease, recent investigations indicate that stem cell therapy may hold great potential to treat children with cardiac defects.

KW - cardiac progenitors

KW - cell therapy

KW - congenital heart disease

KW - hypoplastic left heart syndrome

KW - single ventricle physiology

UR - http://www.scopus.com/inward/record.url?scp=84922634967&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922634967&partnerID=8YFLogxK

M3 - Article

C2 - 25114758

AN - SCOPUS:84922634967

VL - 10

SP - 77

EP - 81

JO - Methodist DeBakey cardiovascular journal

JF - Methodist DeBakey cardiovascular journal

SN - 1947-6094

IS - 2

ER -